BRPI0916233A2 - compostos heterocíclicos antivirais - Google Patents
compostos heterocíclicos antiviraisInfo
- Publication number
- BRPI0916233A2 BRPI0916233A2 BRPI0916233A BRPI0916233A BRPI0916233A2 BR PI0916233 A2 BRPI0916233 A2 BR PI0916233A2 BR PI0916233 A BRPI0916233 A BR PI0916233A BR PI0916233 A BRPI0916233 A BR PI0916233A BR PI0916233 A2 BRPI0916233 A2 BR PI0916233A2
- Authority
- BR
- Brazil
- Prior art keywords
- heterocyclic compounds
- antiviral
- antiviral heterocyclic
- compounds
- heterocyclic
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8284708P | 2008-07-23 | 2008-07-23 | |
| US20792509P | 2009-02-17 | 2009-02-17 | |
| US17983709P | 2009-05-20 | 2009-05-20 | |
| PCT/EP2009/059039 WO2010010017A1 (en) | 2008-07-23 | 2009-07-15 | Heterocyclic antiviral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0916233A2 true BRPI0916233A2 (pt) | 2018-03-13 |
Family
ID=41057595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0916233A BRPI0916233A2 (pt) | 2008-07-23 | 2009-07-15 | compostos heterocíclicos antivirais |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8273773B2 (pt) |
| EP (1) | EP2307372B1 (pt) |
| JP (1) | JP2011528686A (pt) |
| KR (1) | KR20110033291A (pt) |
| CN (1) | CN102099335A (pt) |
| AR (1) | AR072824A1 (pt) |
| AT (1) | ATE555096T1 (pt) |
| AU (1) | AU2009273327A1 (pt) |
| BR (1) | BRPI0916233A2 (pt) |
| CA (1) | CA2730517A1 (pt) |
| CL (1) | CL2011000136A1 (pt) |
| ES (1) | ES2383273T3 (pt) |
| IL (1) | IL209696A0 (pt) |
| MX (1) | MX2011000656A (pt) |
| PE (1) | PE20110409A1 (pt) |
| TW (1) | TW201008922A (pt) |
| WO (1) | WO2010010017A1 (pt) |
| ZA (1) | ZA201009183B (pt) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI534137B (zh) | 2007-09-17 | 2016-05-21 | 艾伯維巴哈馬有限公司 | 抗感染劑及其用途 |
| WO2009039135A1 (en) | 2007-09-17 | 2009-03-26 | Abbott Laboratories | N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| DK2203431T3 (da) | 2007-09-17 | 2011-11-21 | Abbott Lab | Antiinfektiøse pyrimidiner og anvendelser heraf |
| CA2736472A1 (en) * | 2008-09-26 | 2010-04-01 | F. Hoffmann-La Roche Ag | Pyrine or pyrazine derivatives for treating hcv |
| CA2741325A1 (en) * | 2008-10-30 | 2010-05-06 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral arylpyridone derivatives |
| CN102341382A (zh) * | 2009-03-06 | 2012-02-01 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒的杂环化合物 |
| MX2011010049A (es) * | 2009-03-24 | 2011-10-11 | Abbott Lab | Proceso para la preparacion de un compuesto antiviral. |
| CN105924386A (zh) * | 2009-03-25 | 2016-09-07 | Abbvie 公司 | 抗病毒化合物和其用途 |
| SG175774A1 (en) | 2009-04-25 | 2011-12-29 | Hoffmann La Roche | Heterocyclic antiviral compounds |
| EP2432554A1 (en) * | 2009-05-20 | 2012-03-28 | F. Hoffmann-La Roche AG | Heterocyclic antiviral compounds |
| AR084370A1 (es) * | 2009-08-07 | 2013-05-15 | Chugai Pharmaceutical Co Ltd | Derivados de aminopirazol |
| MX2012003170A (es) * | 2009-09-21 | 2012-04-11 | Hoffmann La Roche | Compuestos heterociclicos antivirales. |
| CN102639504A (zh) | 2009-11-21 | 2012-08-15 | 弗·哈夫曼-拉罗切有限公司 | 杂环抗病毒化合物 |
| WO2012009699A2 (en) | 2010-07-16 | 2012-01-19 | Abbott Laboratories | Process for preparing antiviral compounds |
| BR112013001138A2 (pt) | 2010-07-16 | 2016-07-05 | Abbvie Inc | ligantes de fosfina para reações catalíticas |
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| JP5620417B2 (ja) * | 2011-02-07 | 2014-11-05 | 中外製薬株式会社 | アミノピラゾール誘導体を含む医薬 |
| NO2686520T3 (pt) | 2011-06-06 | 2018-03-17 | ||
| TW201329025A (zh) | 2011-11-01 | 2013-07-16 | Astex Therapeutics Ltd | 醫藥化合物 |
| JP6306585B2 (ja) | 2012-07-31 | 2018-04-04 | ダウ グローバル テクノロジーズ エルエルシー | オレフィン重合触媒活性化剤を製造する方法 |
| WO2014095555A1 (en) | 2012-12-19 | 2014-06-26 | Basf Se | New substituted triazoles and imidazoles and their use as fungicides |
| SMT202400092T1 (it) | 2013-06-13 | 2024-05-14 | Akebia Therapeutics Inc | Composizioni e metodi per il trattamento dell'anemia |
| TWI637744B (zh) | 2013-07-31 | 2018-10-11 | 中外製藥股份有限公司 | 含有胺基吡唑衍生物之醫藥製劑 |
| CA2931550C (en) * | 2013-12-13 | 2023-09-26 | Vertex Pharmaceuticals Incorporated | Prodrugs of pyridone amides useful as modulators of sodium channels |
| ES2756175T3 (es) | 2013-12-27 | 2020-04-27 | Chugai Pharmaceutical Co Ltd | Genes mutantes guardián de fgfr y fármacos que se dirigen a los mismos |
| HK1247201A1 (zh) | 2015-01-23 | 2018-09-21 | 阿克比治疗有限公司 | 2-(5-(3-氟苯基)-3-羟基吡啶甲醯胺)乙酸的固体形式、其组合物及用途 |
| PL3277270T3 (pl) | 2015-04-01 | 2022-02-14 | Akebia Therapeutics, Inc. | Kompozycje i sposoby leczenia niedokrwistości |
| EP3312172B1 (en) | 2015-06-17 | 2020-05-06 | Chugai Seiyaku Kabushiki Kaisha | Aminopyrazole derivatives useful as src kinase inhibitors |
| CA3097219A1 (en) | 2018-05-09 | 2019-11-14 | Akebia Therapeutics, Inc. | Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid |
| CN110724091B (zh) * | 2019-12-04 | 2022-03-11 | 阿里生物新材料（常州）有限公司 | 一种6-（二氟甲基）-2-羟基吡啶-3-磺酰氯的合成方法 |
| US12612367B2 (en) | 2019-12-10 | 2026-04-28 | Akebia Therapeutics, Inc. | Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative |
| CN112898200A (zh) * | 2021-01-20 | 2021-06-04 | 都创(上海)医药科技股份有限公司 | 5-溴-6-甲氧基吡啶-2-羧酸酯的合成方法 |
| CN112876409A (zh) * | 2021-01-20 | 2021-06-01 | 都创(上海)医药科技股份有限公司 | 一种2-(5-溴-6-甲氧基吡啶-2-基)乙腈及其衍生物的合成方法 |
| CN117285509B (zh) * | 2023-09-21 | 2026-04-21 | 西南大学 | 氰乙烯桥联的喹诺酮咪唑类及其类似物的制备方法和医药应用 |
| CN117285510B (zh) * | 2023-09-21 | 2026-04-21 | 西南大学 | 苯并吡啶酮乙烯嘧啶类化合物及其制备方法和医药应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6323180B1 (en) | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
| WO2001085172A1 (en) | 2000-05-10 | 2001-11-15 | Smithkline Beecham Corporation | Novel anti-infectives |
| WO2004041818A1 (en) * | 2002-11-01 | 2004-05-21 | Abbott Laboratories | Anti-infective agents |
| US20040097492A1 (en) | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
| DE602005015466D1 (de) * | 2004-08-23 | 2009-08-27 | Hoffmann La Roche | Antivirale 4'-azidonucleoside |
| JP5211068B2 (ja) * | 2006-12-22 | 2013-06-12 | メルク・シャープ・アンド・ドーム・コーポレーション | Ｈｃｖおよび関連するウイルス疾患の治療または予防のための４，５−環インドール誘導体 |
| EP2197842B1 (en) | 2007-08-29 | 2012-05-23 | Schering Corporation | 2, 3-substituted indole derivatives for treating viral infections |
| JP5179585B2 (ja) | 2007-08-29 | 2013-04-10 | メルク・シャープ・アンド・ドーム・コーポレーション | 四環系インドール誘導体およびその使用法 |
| CA2697500A1 (en) | 2007-08-29 | 2009-03-12 | Schering Corporation | 2,3-substituted azaindole derivatives for treating viral infections |
| TWI534137B (zh) | 2007-09-17 | 2016-05-21 | 艾伯維巴哈馬有限公司 | 抗感染劑及其用途 |
| DK2203431T3 (da) | 2007-09-17 | 2011-11-21 | Abbott Lab | Antiinfektiøse pyrimidiner og anvendelser heraf |
| WO2009039135A1 (en) | 2007-09-17 | 2009-03-26 | Abbott Laboratories | N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| CA2705586A1 (en) | 2007-11-16 | 2009-05-22 | Schering Corporation | 3-heterocyclic substituted indole derivatives and methods of use thereof |
| EP2222672B1 (en) | 2007-11-16 | 2013-12-18 | Merck Sharp & Dohme Corp. | 3-aminosulfonyl substituted indole derivatives and methods of use thereof |
| JP5571167B2 (ja) | 2009-03-25 | 2014-08-13 | アッヴィ・インコーポレイテッド | 抗ウイルス組成物およびこの使用 |
| CN105924386A (zh) | 2009-03-25 | 2016-09-07 | Abbvie 公司 | 抗病毒化合物和其用途 |
-
2009
- 2009-07-15 BR BRPI0916233A patent/BRPI0916233A2/pt not_active IP Right Cessation
- 2009-07-15 JP JP2011519125A patent/JP2011528686A/ja active Pending
- 2009-07-15 AU AU2009273327A patent/AU2009273327A1/en not_active Abandoned
- 2009-07-15 MX MX2011000656A patent/MX2011000656A/es not_active Application Discontinuation
- 2009-07-15 ES ES09780611T patent/ES2383273T3/es active Active
- 2009-07-15 CN CN2009801283861A patent/CN102099335A/zh active Pending
- 2009-07-15 WO PCT/EP2009/059039 patent/WO2010010017A1/en not_active Ceased
- 2009-07-15 CA CA2730517A patent/CA2730517A1/en not_active Abandoned
- 2009-07-15 PE PE2011000046A patent/PE20110409A1/es not_active Application Discontinuation
- 2009-07-15 AT AT09780611T patent/ATE555096T1/de active
- 2009-07-15 EP EP09780611A patent/EP2307372B1/en not_active Not-in-force
- 2009-07-15 KR KR1020117003937A patent/KR20110033291A/ko not_active Ceased
- 2009-07-20 AR ARP090102751A patent/AR072824A1/es unknown
- 2009-07-22 TW TW098124765A patent/TW201008922A/zh unknown
- 2009-07-22 US US12/460,658 patent/US8273773B2/en not_active Expired - Fee Related
-
2010
- 2010-12-01 IL IL209696A patent/IL209696A0/en unknown
- 2010-12-21 ZA ZA2010/09183A patent/ZA201009183B/en unknown
-
2011
- 2011-01-21 CL CL2011000136A patent/CL2011000136A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009273327A1 (en) | 2010-01-28 |
| ZA201009183B (en) | 2013-05-29 |
| AR072824A1 (es) | 2010-09-22 |
| ATE555096T1 (de) | 2012-05-15 |
| EP2307372B1 (en) | 2012-04-25 |
| MX2011000656A (es) | 2011-02-23 |
| WO2010010017A1 (en) | 2010-01-28 |
| US20100021423A1 (en) | 2010-01-28 |
| ES2383273T3 (es) | 2012-06-19 |
| CA2730517A1 (en) | 2010-01-28 |
| JP2011528686A (ja) | 2011-11-24 |
| EP2307372A1 (en) | 2011-04-13 |
| TW201008922A (en) | 2010-03-01 |
| CN102099335A (zh) | 2011-06-15 |
| IL209696A0 (en) | 2011-02-28 |
| CL2011000136A1 (es) | 2011-07-08 |
| KR20110033291A (ko) | 2011-03-30 |
| US8273773B2 (en) | 2012-09-25 |
| PE20110409A1 (es) | 2011-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012005616A2 (pt) | compostos antivirais heterocíclicos | |
| BRPI1010852A2 (pt) | compostos antivirais heterocíclicos | |
| ATE539070T1 (de) | Heterozyklische antivirale verbindungen | |
| SMT201600351B (it) | Composti antivirali | |
| BRPI0821349A2 (pt) | compostos antivirais heterocíclicos | |
| BRPI0924121A2 (pt) | compostos antivirais heterocíclicos | |
| ZA201009183B (en) | Heterocyclic antiviral compounds | |
| BRPI0906705A2 (pt) | Composto heterocíclicos | |
| DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
| BRPI0920707A2 (pt) | compostos | |
| DK2242759T3 (da) | Forbindelser | |
| DK2308877T3 (da) | Imidazopyridin-2-on-derivater | |
| BRPI0907435A2 (pt) | Derivados de 5-flúor pirimidina | |
| EP2269990A4 (en) | Heterocyclic compound | |
| DK2185567T3 (da) | Substituerede bicyclolactam-forbindelser | |
| EP2266989A4 (en) | HETEROCYCLIC DERIVATIVES | |
| BRPI1016266A2 (pt) | compostos antivirais heterocíclicos | |
| DK2080901T3 (da) | Vindmølle-vindmålings-kompensation | |
| ATE484507T1 (de) | Heterocyclische spiroverbindungen | |
| DK2323972T3 (da) | C7-fluor-substituerede tetracylinforbindelser | |
| DK2297162T3 (da) | Forbindelser | |
| DK2275414T3 (da) | Cyclopentylacrylamidderivat | |
| BRPI0920496A2 (pt) | derivados substituídos de pirimidina etriazina | |
| ATE545635T1 (de) | Substituierte n-oxidpyrazinderivate | |
| EP2295406A4 (en) | HETEROCYCLIC CONNECTION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |